help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Langer, I.
Right arrow Articles by Robberecht, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Langer, I.
Right arrow Articles by Robberecht, P.
Molecular Endocrinology 16 (5): 1089-1096
Copyright © 2002 by The Endocrine Society

A Small Sequence in the Third Intracellular Loop of the VPAC1 Receptor Is Responsible for Its Efficient Coupling to the Calcium Effector

Ingrid Langer, Pascale Vertongen, Jason Perret, Magali Waelbroeck and Patrick Robberecht

Department of Biological Chemistry and Nutrition, Faculty of Medicine, Université Libre de Bruxelles, B-1070 Brussels, Belgium

Address all correspondence and requests for reprints to: Dr. Ingrid Langer, Department of Biological Chemistry and Nutrition, Université Libre de Bruxelles, Faculty of Medicine, Bat GE, CP 611, 808 Route de Lennik, B-1070 Brussels, Belgium. E-mail: ilanger{at}ulb.ac.be.

The stimulatory effect of VIP on intracellular calcium concentration ([Ca2+]i) has been investigated in Chinese hamster ovary cells stably transfected with the reporter gene aequorin, and expressing human VPAC1, VPAC2, chimeric VPAC1/VPAC2, or mutated receptors. The VIP-induced [Ca2+]i increase was linearly correlated with receptor density and was higher in cells expressing VPAC1 receptors than in cells expressing a similar VPAC2 receptor density. The study was performed to establish the receptor sequence responsible for that difference. VPAC1/VPAC2 chimeric receptors were first used for a broad positioning: those having the third intracellular loop (IC3) of the VPAC1 or of the VPAC2 receptor behaved, in that respect, phenotypically like VPAC1 and VPAC2 receptor, respectively. Replacement in the VPAC2 receptor of the sequence 315–318 (VGGN) within the IC3 by its VPAC1 receptor counterpart 328–331 (IRKS) and the introduction of VGGN in state of IRKS in VPAC1 was sufficient to mimic the VPAC1 and VPAC2 receptor characteristics, respectively.

Thus, a small sequence in the IC3 of the VPAC1 receptor, probably through interaction with G{alpha}i and G{alpha}q proteins, is responsible for the efficient agonist-stimulated [Ca2+]i increase.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. Langlet, I. Langer, P. Vertongen, N. Gaspard, J.-M. Vanderwinden, and P. Robberecht
Contribution of the Carboxyl Terminus of the VPAC1 Receptor to Agonist-induced Receptor Phosphorylation, Internalization, and Recycling
J. Biol. Chem., July 29, 2005; 280(30): 28034 - 28043.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
I. Langer, C. Langlet, and P. Robberecht
Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor
J. Mol. Endocrinol., April 1, 2005; 34(2): 405 - 414.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
D. Yin, S. Gavi, H.-y. Wang, and C. C. Malbon
Probing Receptor Structure/Function with Chimeric G-Protein-Coupled Receptors
Mol. Pharmacol., June 1, 2004; 65(6): 1323 - 1332.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society